We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discusses.
A caller asked what Cramer thought of Moderna, Inc., and he said:
“There’s gotta be some value in Moderna. There just has to be, but I’ve been against this stock for so long. I first discovered it at 18. Maybe that should be the price target.”
A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine.
Moderna is a biotech company focused on creating vaccines and treatments using messenger RNA technology. The company works on solutions for various diseases. On March 26, highlighting the stock’s decline, Cramer said:
“Now, let’s consider the other side of the trade, the biggest losers, all of which were somehow connected to the data center except Moderna, which plunged 7% because of Financial Time’s story. It says they might… be targeted by RFK Junior at Health and Human Services and it’s certainly possible.”
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
This article is originally published at Insider Monkey.
